274 related articles for article (PubMed ID: 19450859)
1. The prognostic impact of comorbidities on renal cancer, 1995 to 2006: a Danish population based study.
Lund L; Jacobsen J; Nørgaard M; McLaughlin JK; Blot WJ; Borre M; Sørensen HT
J Urol; 2009 Jul; 182(1):35-40; discussion 40. PubMed ID: 19450859
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbidity on survival of Danish prostate cancer patients, 1995-2006: a population-based cohort study.
Lund L; Borre M; Jacobsen J; Sørensen HT; Nørgaard M
Urology; 2008 Dec; 72(6):1258-62. PubMed ID: 18342917
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
4. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
5. A Mediterranean age-comorbidity prognostic index for survival in dialysis populations.
Fernandez Lucas M; Teruel JL; Zamora J; Lopez Mateos M; Rivera M; Ortuno J
J Nephrol; 2007; 20(6):696-702. PubMed ID: 18046672
[TBL] [Abstract][Full Text] [Related]
6. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
[TBL] [Abstract][Full Text] [Related]
7. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on survival of invasive bladder cancer patients, 1996-2007: a Danish population-based cohort study.
Lund L; Jacobsen J; Clark P; Borre M; Nørgaard M;
Urology; 2010 Feb; 75(2):393-8. PubMed ID: 19914698
[TBL] [Abstract][Full Text] [Related]
9. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
[TBL] [Abstract][Full Text] [Related]
10. The impact of pre-admission morbidity level on 3-year mortality after intensive care: a Danish cohort study.
Christiansen CF; Christensen S; Johansen MB; Larsen KM; Tønnesen E; Sørensen HT
Acta Anaesthesiol Scand; 2011 Sep; 55(8):962-70. PubMed ID: 21770901
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
[TBL] [Abstract][Full Text] [Related]
12. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
[TBL] [Abstract][Full Text] [Related]
13. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
15. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.
Murray SB; Bates DW; Ngo L; Ufberg JW; Shapiro NI
Acad Emerg Med; 2006 May; 13(5):530-6. PubMed ID: 16551775
[TBL] [Abstract][Full Text] [Related]
16. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
Beisland C; Hjelle KM; Reisaeter LA; Bostad L
Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
18. The impact of obesity on overall and cancer specific survival in men with prostate cancer.
Davies BJ; Smaldone MC; Sadetsky N; Dall'era M; Carroll PR
J Urol; 2009 Jul; 182(1):112-7; discussion 117. PubMed ID: 19447437
[TBL] [Abstract][Full Text] [Related]
19. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival.
Kannegaard PN; van der Mark S; Eiken P; Abrahamsen B
Age Ageing; 2010 Mar; 39(2):203-9. PubMed ID: 20075035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
